How to Incorporate Subcutaneous Infliximab and Vedolizumab in Your Practice

Affiliations

¹ Department of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: sara.n.horst@vumc.org.
² Department of Pharmacy, UC San Diego Health, San Diego, California.
³ Department of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee.
⁴ Service d'Hépato-Gastro Entérologie, 3iHP, French Institute of Health and Medical Research, Centre Hospitalier Universitaire Clermont-Ferrand, Université Clermont Auvergne, Clermont-Ferrand, France; USC-INRA 2018, M2iSH, Inserm U1071, 3iHP, French Institute of Health and Medical Research, Centre Hospitalier Universitaire Clermont-Ferrand, Clermont-Ferrand, France. Electronic address: a_buisson@hotmail.fr.

Sara N Horst et al. Clin Gastroenterol Hepatol. 2025 Feb.

. 2025 Feb;23(2):216-219.e2.

doi: 10.1016/j.cgh.2024.07.042. Epub 2024 Oct 8.

¹ Department of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: sara.n.horst@vumc.org.
² Department of Pharmacy, UC San Diego Health, San Diego, California.
³ Department of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee.
⁴ Service d'Hépato-Gastro Entérologie, 3iHP, French Institute of Health and Medical Research, Centre Hospitalier Universitaire Clermont-Ferrand, Université Clermont Auvergne, Clermont-Ferrand, France; USC-INRA 2018, M2iSH, Inserm U1071, 3iHP, French Institute of Health and Medical Research, Centre Hospitalier Universitaire Clermont-Ferrand, Clermont-Ferrand, France. Electronic address: a_buisson@hotmail.fr.

No abstract available

LinkOut - more resources